The science of obesity
Learn more about the condition that currently affects more than one-third of U.S. adults.1
Access information and resources on each of our obesity products.
Access our library of recently presented posters, abstracts and presentations.
Obesity and COVID-19
Take a deep dive into the data and recommendations revealing how COVID-19 interacts with obesity and other disease states, gathered from a variety of expert sources.
Overview of Current and Emerging Weight-Loss Pharmacotherapies (IME content)
Review outcomes and warnings for weight-loss medications currently approved by the FDA.
1. Prevalence of Obesity Among Adults and Youth: United States, 2011–2014. NCHS Data Brief, No. 219, November 2015.
Questions about obesity research or other disease states?
Speak to a live medical information specialist or submit a question via our web form.
For other therapeutic areas, visit our Novo Nordisk Medical website.